Parallel Advisors, LLC Meridian Bioscience Inc Transaction History

Parallel Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$31.15 - $33.39 $2,024 - $2,170	-65 Reduced 61.9%	40 $1,000
Q3 2022 Nov 10, 2022	BUY	$30.9 - $33.55 $2,008 - $2,180	65 Added 162.5%	105 $3,000
Q1 2022 Apr 28, 2022	SELL	$19.97 - $26.94 $279 - $377	-14 Reduced 25.93%	40 $1,000
Q4 2021 Jan 20, 2022	BUY	$17.46 - $21.61 $942 - $1,166	54 New	54 $1,000
Q2 2019 Aug 05, 2019	SELL	$10.88 - $17.6 $1,664 - $2,692	-153 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$13.45 - $14.35 $2,057 - $2,195	153 New	153 $2,000
Q3 2017 Nov 14, 2017	SELL	$13.45 - $14.35 $7,020 - $7,490	-522 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	522	522 $7,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.